Drug discovery, new disease cures, advancements in pharma and biomedicine. Along with direct dividends or shares - as is currently being discussed - these are the only viable ways to turn public sentiment around. The big push will start to happen in 2027.
Andrew Curran says AI drug discovery will drive public sentiment in 2027
AIAndrew Curran says drug discovery, new disease cures, and advances in pharma and biomedicine are the only viable ways to turn public sentiment around on AI, with direct dividends or shares also being discussed. He predicts the big push will start in 2027.
Andrew CurranVerified on X
@AndrewCurran_
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! https://openai.com/index/openai-to-acquire-orchestra-bio/View quoted post on X
Source details
Andrew Curran · x.comPublished
Original title: Drug discovery, new disease cures, advancements in pharma and biomedicine. Along with direct dividends or shares - as is currently being ...